Crossmark

Cancer cell targeting and therapeutic delivery of silver nanoparticles by mesoporous silica nanocarriers: insights into the action mechanisms using quantitative proteomics

Crossref DOI link: https://doi.org/10.1039/C8NR07667G

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Montalvo-Quiros, Sandra

Aragoneses-Cazorla, Guillermo

Garcia-Alcalde, Laura

Vallet-Regí, María https://orcid.org/0000-0002-6104-4889
González, Blanca https://orcid.org/0000-0002-0493-6071
Luque-Garcia, Jose L. https://orcid.org/0000-0001-6273-0349
Funding

Funding for this research was provided by:

Ministerio de Economía y Competitividad (CTQ2017-85673-R)

Ministerio de Economía y Competitividad (MAT2015-64831-R)

Ministerio de Economía y Competitividad (MAT2016-75611-R)

H2020 European Research Council (ERC-2015-AdG (VERDI) 694160)

Instituto de Salud Carlos III (PI15/00978)

European Regional Development Fund

Ministerio de Educación, Cultura y Deporte (FPU13/00723)
License Information

Accepted Manuscript valid from 2020-02-12
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: María Vallet-Regí (ORCID)

: María Vallet-Regí (ResearcherID)

: Blanca González (ORCID)

: Jose L. Luque-Garcia (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 20 September 2018; Accepted 9 February 2019; Accepted Manuscript published 12 February 2019; Advance Article published 26 February 2019; Version of Record published 7 March 2019

Document is current

Any future updates will be listed below